MRI Contrast
MRI Contrast is an intervention with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk
Central Vein Sign in Multiple Sclerosis Extension Study
Dynamic Measurement of Cerebrospinal Fluid in Healthy Subjects: Pilot Study
National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
Clinical Trials (7)
Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk
Central Vein Sign in Multiple Sclerosis Extension Study
Dynamic Measurement of Cerebrospinal Fluid in Healthy Subjects: Pilot Study
National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
Magnetic Resonance Imaging Development for High Resolution Atrial Structural and Functional Characterization
Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI
All 7 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 7